Aberrant gene expression by CD25+CD4+ immunoregulatory T cells in autoimmune-prone rats carrying the human T cell leukemia virus type-I gene

International Immunology

Volumn 17, Issue 6, 2005, Pages 677-684

  Hayase, Hiroko ^a   Ishizu, Akihiro ^a   Ikeda, Hitoshi ^a,c   Miyatake, Yukiko ^a   Baba, Tomohisa ^a   Higuchi, Masato ^a   Abe, Asami ^a   Tomaru, Utano ^a   Yoshiki, Takashi ^a,b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GeneticLab Co Ltd   (Japan)

^c HAKODATE CENTRAL GENERAL HOSPITAL   (Japan)

Author keywords

Animal model; Foxp3; JAK STAT; SOCS; T reg

Indexed keywords

CD4 ANTIGEN; CYTOKINE; INTERLEUKIN 2 RECEPTOR ALPHA; JANUS KINASE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTION FACTOR FOXP3; CYTOKINE INDUCIBLE SH2 CONTAINING PROTEIN; CYTOKINE INDUCIBLE SH2-CONTAINING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, RAT; IMMEDIATE EARLY PROTEIN; INTERLEUKIN 2 RECEPTOR; JAK1 PROTEIN, HUMAN; JAK1 PROTEIN, RAT; JANUS KINASE 1; LEUKOCYTE ANTIGEN; PROTEIN TYROSINE KINASE; SOCS1 PROTEIN, RAT; SOCS2 PROTEIN, RAT; SOCS3 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; ENV PX GENE; ENVELOPE GENE; GENE EXPRESSION; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RAT; RAT STRAIN; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENE; UNINDEXED SEQUENCE; VIRUS GENE; WILD TYPE; ANIMAL; BIOSYNTHESIS; BONE MARROW TRANSPLANTATION; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; SPLEEN; TRANSGENIC ANIMAL; VIROLOGY;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD; ANTIGENS, CD4; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMEDIATE-EARLY PROTEINS; JANUS KINASE 1; MALE; PROTEIN-TYROSINE KINASES; RATS; RECEPTORS, INTERLEUKIN-2; SPLEEN; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES;

EID: 26444464428     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh238     Document Type: Article

References (42)

1. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D. and Gallo, R. C. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T -cell lymphoma. Proc. Natl Acad. Sci. USA 77:7415.
2. Yoshida, M., Miyoshi, I. and Hinuma, Y. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl Acad. Sci. USA 79:2031.
3. Gessain, A., Barin, F., Vernant, J. C. et al. 1985. Antibodies to human T-lymphotropic virus typed-I in patients with tropical spastic paraparesis. Lancet 2:407.
4. Osame, M., Usuku, K., Izumo, S. et al. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031.
5. Mochizuki, M., Watanabe, T., Yamaguchi, K. et al. 1992. HTLV-I uveitis: A distinct clinical entity caused by HTLV-I. Jpn. J. Cancer Res. 83:236.
6. Nishioka, K., Maruyama, I., Sato, K., Kitajima, I., Nakajima, Y. and Osame, M. 1989. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1:441.
7. Vernant, J. C., Buisson, G., Magdeleine, J. et al. 1988. T lymphocyte alveolitis, tropical spastic paraparesis, and Sjögren's syndrome. Lancet 1:177.
8. Sugimoto, M., Nakashima, H., Watanabe, S. et al. 1987. T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 2:1220.
9. LaGrenade, L., Hanchard, B., Fletcher, V., Cranston, B. and Blattner, W. 1990. Infective dermatitis of Jamaican children: A marker for HTLV-I infection. Lancet 336:1345.
10. Yamazaki, H., Ikeda, H., Ishizu, A. et al. 1997. A wide spectrum of collagen vascular and autoimmune diseases in transgenic rats carrying the env-pX gene of human T lymphocyte virus type I. Int. Immunol. 9:339.
11. Yamazaki, H., Kunisada, T., Ishizu, A. et al. 1998. Promotion of early osteogenesis and B lymphopoiesis in the bone marrow of transgenic rats with the env-pX gene of human T-cell lymphotropic virus type I. Oncogene 17:2955.
12. Nakamaru, Y., Ishizu, A., Ikeda, H. et al. 2001. Immunological hyper-responsiveness in HTLV-I LTR-env-pX transgenic rats: A prototype animal model for collagen vascular and HTLV-I-related inflammatory diseases. Pathobiology 69:11.
13. Fugo, K., Ishizu, A., Ikeda, H. et al. 2002. The role of the thymus in development of necrotizing arteritis in transgenic rats carrying the env-pX gene of human T-cell leukemia virus type-I. Am. J. Pathol. 161:755.
14. + immunoregulatory T cells in a transgenic rat model of autoimmune diseases. J. Autoimmun. 20:43.
15. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162:5317.
16. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301.
17. Miyatake, Y., Ikeda, H., Michimata, R. et al. 2004. Differential modulation of gene expression among rat tissues with warm ischemia. Exp. Mol. Pathol. 77:222.
18. Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057.
19. + regulatory T cells. Nat. Immunol. 4:330.
20. Kampinga, J., Groen, H., Klatter, F. et al. 1992. Post-thymic T cell development in rats: An update. Biochem. Soc. Trans. 20:191.
21. Sarawar, S. R., Sparshott, S. M., Sutton, P., Yang, C. P., Hutchinson, I. V. and Bell, E. B. 1993. Rapid re-expression of CD45RC on rat CD4 T cells in vitro correlates with a change in function. Eur. J. Immunol. 23:103.
22. Waldmann, T. A. 1986. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science 232:727.
23. Kodaka, T., Uchiyama, T., Ishikawa, T. et al. 1990. Interleukin-2 receptor beta-chain (p70-75) expressed on leukemic cells from adult T cell leukemia patients. Jpn. J. Cancer Res. 81:902.
24. Starr, R., Willson, T. A., Viney, E. M. et al. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917.
25. Alexander, W. S. and Hilton, D. J. 2004. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22:503.
26. + regulatory T cells for immunologic self-tolerance and negative control of immune reponses. Annu. Rev. Immunol. 22:531.
27. Sakaguchi, S., Fukuma, K., Kuribayashi, K. and Masuda, T. 1985. Organ specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self tolerance; deficit of a T cell subset as a possible cause of autoimmune diseases. J. Exp. Med. 161:72.
28. Sugihara, S., Izumi, Y., Yoshioka, T. et al. 1988. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis. J. Immunol. 14:105.
29. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151.
30. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A. et al. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68.
31. + T cell levels in NOD mice. Proc. Natl Acad. Sci. USA 99:12287.
32. + regulatory T cells: Thymus or periphery. J. Clin. Investig. 112:1310.
33. Rane, S. G. and Reddy, E. P. 2000. Janus kinases: Components of multiple signaling pathways. Oncogene 19:5662.
34. Bromberg, J. F. 2001. Activation of STAT proteins and growth control. Bioessays 23:161.
35. Schindler, C. 1999. Cytokines and JAK-STAT signaling. Exp. Cell Res. 253:7.
36. Ivashkiv, L. B. 2000. Jak-STAT signaling pathways in cells of the immune system. Rev. Immunogenet. 2:220.
37. + immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311.
38. Migone, T. S., Lin, J. X., Cereseto, A. et al. 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269:79.
39. Xu, X., Kang, S. H., Heidenreich, O., Okerholm, M., O'Shea, J. J. and Nerenberg, M. I. 1995. Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) Tax protein or virus-transformed cells. J. Clin. Investig. 96:1548.
40. Yu, C. R., Mahdi, R. M., Ebong, S. et al. 2004. Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling. J. Immunol. 173:737.
41. Gatza, M. L., Watt, J. C. and Marriott, S. J. 2003. Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades. Oncogene 22:5141.
42. Bennett, C. L., Christie, J., Ramsdell, F. et al. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20.